SURI vs. CNCR

Last updated Jun 4, 2026

SURI (Simplify Propel Opportunities ETF) and CNCR (Loncar Cancer Immunotherapy ETF) are both Health & Biotech Equities funds. SURI is actively managed, while CNCR is passively managed. SURI charges 2.51%/yr vs 0.79%/yr for CNCR.

Performance

SURI vs. CNCR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Simplify Propel Opportunities ETF (SURI) and Loncar Cancer Immunotherapy ETF (CNCR). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

SURI

• 1D: -1.15%
• 1M: -2.84%
• YTD: 6.10%
• 6M: 3.98%
• 1Y: 32.89%
• 3Y*: 6.93%
• 5Y*: —
• 10Y*: —

CNCR

• 1D: 0.00%
• 1M: 0.00%
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

SURI vs. CNCR - Yearly Performance Comparison

	2026 (YTD)
SURI Simplify Propel Opportunities ETF	9.88%
CNCR Loncar Cancer Immunotherapy ETF	0.00%

SURI vs. CNCR - Sectors Allocation Comparison

Sectors	SURI	CNCR
Healthcare	56.4%	96.6%
Energy	43.6%	-
Basic Materials	-	-
Communication Services	-	-
Consumer Cyclical	-	-
Consumer Defensive	-	-
Financial Services	-	3.3%
Industrials	-	-
Real Estate	-	-
Technology	-	-
Utilities	-	-

Return for Risk

SURI vs. CNCR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SURI

SURI Risk / Return Rank: 45
SURI Sharpe Ratio Rank: 41
SURI Sortino Ratio Rank: 42
SURI Omega Ratio Rank: 39
SURI Calmar Ratio Rank: 57
SURI Martin Ratio Rank: 48

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SURI vs. CNCR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Simplify Propel Opportunities ETF (SURI) and Loncar Cancer Immunotherapy ETF (CNCR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	SURI	CNCR	Difference
Sharpe ratio: Return per unit of total volatility	1.46	—	—
Sortino ratio: Return per unit of downside risk	2.11	—	—
Omega ratio: Gain probability vs. loss probability	1.26	—	—
Calmar ratio: Return relative to maximum drawdown	2.81	—	—
Martin ratio: Return relative to average drawdown	7.91	—	—
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

Sharpe Ratios by Period

	SURI	CNCR	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.46	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.15	—	—

Drawdowns

SURI vs. CNCR - Drawdown Comparison

The maximum SURI drawdown since its inception was -47.76%, which is greater than CNCR's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for SURI and CNCR.

Drawdown Indicators

	SURI	CNCR	Difference
Max Drawdown Largest peak-to-trough decline	-47.76%	0.00%	-47.76%
Max Drawdown (1Y) Largest decline over 1 year	-11.78%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-47.76%	—	—
Current Drawdown Current decline from peak	-17.46%	0.00%	-17.46%
Average Drawdown Average peak-to-trough decline	-17.37%	0.00%	-17.37%
Ulcer Index Depth and duration of drawdowns from previous peaks	4.17%	—	—

Volatility

Volatility by Period

	SURI	CNCR	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.89%	—	—
Volatility (6M) Calculated over the trailing 6-month period	14.29%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	22.79%	0.00%	+22.79%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	28.27%	0.00%	+28.27%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	28.27%	0.00%	+28.27%

SURI vs. CNCR - Expense Ratio Comparison

SURI has a 2.51% expense ratio, which is higher than CNCR's 0.79% expense ratio.

Dividends

SURI vs. CNCR - Dividend Comparison

SURI's dividend yield for the trailing twelve months is around 16.04%, while CNCR has not paid dividends to shareholders.

Position	TTM	2025	2024	2023
CNCR Loncar Cancer Immunotherapy ETF	0.00%	0.00%	0.00%	0.00%
SURI Simplify Propel Opportunities ETF	16.04%	16.31%	21.41%	14.71%

Frequently Asked Questions

Which ETF is better, SURI or CNCR?

On fees, CNCR is cheaper at 0.79% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, SURI or CNCR?

CNCR is cheaper with a 0.79% expense ratio, compared with 2.51% for SURI.

Which ETF pays a higher dividend yield, SURI or CNCR?

SURI has the higher dividend yield at 16.04%, compared with 0.00% for CNCR.

What is the main difference between SURI and CNCR?

They also come from different issuers: Simplify and Exchange Traded Concepts. Their fees differ too: 2.51% for SURI and 0.79% for CNCR.